A Harvard Neuroscientist Says We’re Medicating Normal Human Behavior | Dr. Adam Omary EP 237

A Harvard Neuroscientist Says We’re Medicating Normal Human Behavior | Dr. Adam Omary EP 237

June 11, 2026 · 1h 22m

About this episode

Dr. Adam Omary discusses the implications of recent data on mental health diagnoses and treatments.

Dr. Adam Omary is a psychologist, neuroscientist, and researcher at the Cato Institute. His doctoral work at Harvard focused on the rise in gender dysphoria among adolescent girls, and he is currently writing a book on the psychology of progress. In this episode, we discuss what the latest data on puberty blockers shows, why psychiatric diagnoses continue to rise despite living in one of the safest and most prosperous periods in human history, and how incentives within the mental health system may be contributing to overdiagnosis. We also get into the rapid increase in autism diagnoses following the pandemic, the expansion of the DSM, SSRI use among young adults, smartphone bans in schools, social media and mental health, and the difference between normal human suffering and psychiatric illness. Topics: • New data on puberty blockers • Gender dysphoria research • SSRI use in Gen Z • The expansion of the DSM • Overdiagnosis in psychiatry • Autism diagnoses after COVID • Smartphone bans in schools • Social media and mental health • Grief vs. major depressive disorder • Incentives in the mental health industry • The psychology of progress Find Dr. Omary: humanprogress.org Cato…

People in this episode

Host: Mikhaila Peterson

Guest: Dr. Adam Omary

Topics covered

Keywords

Mentioned in this episode

Organizations: Cato Institute, Peterson Academy, Fuller Research Foundation, Lion Diet, Biotoxin

Explore listener stats, chart rankings, contacts and more on the The Mikhaila Peterson Podcast podcast page.